5 days a week versus 6 days a week fractionated Radiotherapy in Cervical Carcinoma

Accelerated versus conventionally fractionated Radiotherapy in Cervical Cancer: A Prospective study - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054226

Enrollment

Registered

2023-06-21

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

Intervention1: Concurrent Chemoradiotherapy followed by Brachytherapy: 45Gy in 25#, 1.8Gy per #, 6# per week over 4.1 weeks followed by ICR or ISBT Control Intervention1: Concurrent Chemoradiotherapy

Eligibility

Inclusion criteria

Inclusion criteria: 18- to 65- year-old females with histologically proven carcinoma cervix stage IB3 to IVA

Exclusion criteria

Exclusion criteria: Patients previously treated for any pelvic malignancy, lactating and pregnant females

Design outcomes

Primary

Measure	Time frame
Local control, Disease Free survival & Overall survivalTimepoint: 5 years	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactSachin S

Banaras Hindu University

sachinsdpi98@gmail.com7010200358

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026